Rockwell Medical (RMTI) announced that the Company has renewed and extended its product purchase agreement with aQua Dialysis a leading independent provider of in-center hemodialysis and home dialysis services in Texas. The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will continue to supply aQua Dialysis with the Company’s liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis related products.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMTI:
- Rockwell Medical signs new product purchase agreement with Heritage Dialysis
- Rockwell Medical: Profitability Path and Cash-Flow Upside Drive Reiterated Buy Rating and Unchanged $2 Price Target
- Rockwell Medical Charts Margin-Focused Path to 2026 Profit
- Rockwell Medical Faces Nasdaq Compliance Challenge, Eyes Reverse Split
- Rockwell Medical Issues Updated Investor Corporate Presentation